Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia.
about
The pharmacokinetic-pharmacodynamic model of azithromycin for lipopolysaccharide-induced depressive-like behavior in miceCytokine kinetics and other host factors in response to pneumococcal pulmonary infection in miceComparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae.Penetration of meropenem in lung, bronchial mucosa, and pleural tissuesIn vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilisIn vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin GDouble-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis.Haemophilus influenzae responds to glucocorticoids used in asthma therapy by modulation of biofilm formation and antibiotic resistancePharmacokinetics of tulathromycin in healthy and neutropenic mice challenged intranasally with lipopolysaccharide from Escherichia coliPharmacokinetics of antibacterial agents in the CSF of children and adolescents.Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.Clinical relevance of intracellular and extracellular concentrations of macrolides.Antibiotic penetration into lung tissues.In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin.Pulmonary pharmacokinetics of tulathromycin in swine. Part I: Lung homogenate in healthy pigs and pigs challenged intratracheally with lipopolysaccharide of Escherichia coli.Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.Penetration of ertapenem into different pulmonary compartments of patients undergoing lung surgery.
P2860
Q28485282-E5891FC7-BB59-49E5-88D7-719108E166CEQ33501805-9A054E59-F9D2-4726-A5CC-119CB211A908Q33689995-E2817FCF-C770-40CC-A3EF-696CD2F72A02Q33748466-E1940C0F-08FE-4339-8EFB-4D47B480EFCEQ33752955-C189C980-D433-4DA3-ABC1-DB185D520FAEQ33976524-95BD4CE7-CF99-49DD-8E65-CF45B8516D64Q34732986-D4AD5C0F-A524-4814-8713-3538ECD405D7Q35118043-598DD548-E242-48E9-AD22-C4EE573CEF9EQ35885023-67D6668B-28A3-43EE-AC0A-E96C7E230388Q36000796-19B1B37F-BCD9-4FEB-AD3B-569A39C42D1AQ36171670-9341F1FC-42F0-4A01-9AE6-D5D2454047D9Q38093135-B1E8E31D-1721-42BE-B89D-2452DB65A917Q38151858-C20F0762-6A3A-4873-A8EC-CDE28446AC31Q40545419-A5FF6767-94AA-4F2B-A0FA-4956818CE5BDQ42417997-8C7C59D9-734D-4032-8692-2CD09DDFF079Q43744039-32179152-2ADD-4A99-8B8F-6845C2FF33A4Q43917247-F3A7491E-8D60-4F1A-ADE7-3455D7F3BC16Q44275415-B39C56EB-7EEE-495B-9736-DBD4CC26FD84Q46490969-12A0B274-5AA8-469D-82D1-E0CCA992D07BQ46497112-A2DB6FAC-BF5A-44BF-9B94-4B50FB6935B4
P2860
Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia.
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Prophylactic and therapeutic a ...... del of pneumococcal pneumonia.
@ast
Prophylactic and therapeutic a ...... del of pneumococcal pneumonia.
@en
type
label
Prophylactic and therapeutic a ...... del of pneumococcal pneumonia.
@ast
Prophylactic and therapeutic a ...... del of pneumococcal pneumonia.
@en
prefLabel
Prophylactic and therapeutic a ...... del of pneumococcal pneumonia.
@ast
Prophylactic and therapeutic a ...... del of pneumococcal pneumonia.
@en
P2093
P2860
P356
P1476
Prophylactic and therapeutic a ...... del of pneumococcal pneumonia.
@en
P2093
Azoulay-Dupuis E
Muffat-Joly M
Pocidalo JJ
P2860
P304
P356
10.1128/AAC.35.6.1024
P407
P577
1991-06-01T00:00:00Z